Tumor Targeting with an isoDGR-Drug Conjugate

about

Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αV β3.Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting.

P2860

Q42801541-09D54E28-49EC-4FCF-B838-9C95EEDA8314 Q55338721-3FB10495-961B-4554-8E9E-CE1540F7D9BC

P2860

Tumor Targeting with an isoDGR-Drug Conjugate

Item

http://www.wikidata.org/entity/Q41019174

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Tumor Targeting with an isoDGR-Drug Conjugate

@en

type

Item

label

Tumor Targeting with an isoDGR-Drug Conjugate

@en

prefLabel

Tumor Targeting with an isoDGR-Drug Conjugate

@en

P1476

Tumor Targeting with an isoDGR-Drug Conjugate

@en

P2093

Aurelio Marsiglio

http://www.w3.org/2001/XMLSchema#string

Clara Albanese

http://www.w3.org/2001/XMLSchema#string

Fabio Gasparri

http://www.w3.org/2001/XMLSchema#string

Ivan Fraietta

http://www.w3.org/2001/XMLSchema#string

Michele Caruso

http://www.w3.org/2001/XMLSchema#string

Silvia Panzeri

http://www.w3.org/2001/XMLSchema#string

Simona Angerani

http://www.w3.org/2001/XMLSchema#string

P2860

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.

Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.

Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.

Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries.

The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction.

Protease-activated drug development.

Small molecule toxins targeting tumor receptors.

Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors

Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.

P304

7910-7914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201701844

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28449309

http://www.w3.org/2001/XMLSchema#string

P932

5488297

http://www.w3.org/2001/XMLSchema#string

Tumor Targeting with an isoDGR-Drug Conjugate

about

P2860

P2860

Tumor Targeting with an isoDGR-Drug Conjugate

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932